Paget Disease of the Vulva

1

Review clinical trials related to Paget Disease of the Vulva. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).

Vulvar Paget's disease is a rare skin tumour which affect Caucasian post-menopausal women. The disease is revealed by erythematous, eczematous, pruritus and vulvar burns. The diagnosis is often late (from a few months to several years) because the symptoms are neglected by patients or misinterpreted by doctors. The reference treatment is based on surgical excision but unfortunately local recurrences are very frequent (17 to 38% of cases). Photodynamic therapy (PDT) is already used in some dermatological pathologies and could therefore be an alternative treatment. The objective of this study is to assess the efficacy and evaluate the safety of the new PDT device "PAGETEX" for the treatment of vulvar Paget's disease.

Participants needed: 24
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University Hospital, LilleUpdated: May 5, 2026Locations: 1
Eligibility criteria

Non-invasive, primary or recurrent vulvar Paget's disease after surgical resecti... [+4]

Invasive vulvar Paget's Disease [+15]